It has been going on two months since we last took a detailed look at the pandemic. Of course, a lot has happened since then. Between the winter wave of Delta, the emergence of Omicron, and the rising hospitalizations putting regional health care systems at risk again, there is a concern as to whether we are entering a third pandemic. I don’t think so, at this point. But let’s take a detailed look at where we are now and at the real question going forward—how bad will this get?

Over the past month, we have done a couple of posts about ESG investing, notably from my younger colleagues. I have gotten—not pushback, really—but comments to that effect both on the blog and elsewhere. The feeling seems to be, at least to some extent, that ESG is different from what prior generations, which is to say old people (which is to say me), have looked at and that somehow this represents a change.

My colleague Sam Millette, manager, fixed income on Commonwealth’s Investment Management and Research team, has helped me put together this month’s Market Risk Update. Thanks for the assist, Sam!

My colleague Sam Millette, manager, fixed income on Commonwealth’s Investment Management and Research team, has helped me put together this month’s Economic Risk Factor Update. Thanks for the assist, Sam!

Last week saw a number of important economic data releases, with a focus on consumer and business confidence and the November employment report. The jobs report showed a notable slowdown in headline job growth in November, although the month’s underlying data was more encouraging. This week will be relatively quiet, with only three major data releases scheduled. They will cover international trade, consumer inflation, and a first look at consumer sentiment in December.

Brad here. What is the next crisis? We get this question a lot. To keep up on such trends, we have to watch many things, such as countries getting into trouble. Turkey, which is currently struggling with the financial markets, is one of those countries we are watching—but not, as Anu Gaggar shows, all that worried about. This is a good case study of how we keep an eye on emerging risks. Thanks, Anu!

November was a solid month for the economy but difficult in terms of both the medical news and financial markets. After a strong October, the Fed announced plans to start tightening monetary policy. Then we heard about a new variant of COVID-19. By month-end, the combined news pulled the markets down from midmonth gains to much more mixed results.

After a strong October, November saw generally weak performance in the markets. In the U.S., the Nasdaq showed a small gain, but the S&P and the Dow were down. These results were driven by the emergence of the Omicron variant and the Fed’s announcement that it would start to normalize monetary policy. Still, hiring for October was healthy, and layoffs dropped to pre-pandemic levels in November.

Once again, we have some volatility in the financial markets. With the appearance of the Omicron variant of the COVID virus, stocks have pulled back. This has caused all sorts of speculation about the resurgence of the pandemic, the derailing of the economy, and more significant downturns in the market. It’s time for a deep breath, as always, and a determination of what is—not what could or might be—happening.

Last week saw a number of important economic updates, with reports on home sales, durable goods orders, personal income and spending, and the most recent FOMC meeting. Among the largely positive reports, the better-than-expected personal income and spending growth provided a highlight. This week will be another busy one for data updates, with a focus on consumer and business confidence and the November employment report.